37,607 results on '"PURINES"'
Search Results
2. Dysregulated Purinergic Signalling in Fragile X Syndrome Cortical Astrocytes.
- Author
-
Reynolds, Kathryn E., Napier, Matthew, Fei, Fan, Green, Kirk, and Scott, Angela L.
- Abstract
The symptoms of fragile X syndrome (FXS), caused by a single gene mutation to Fmr1, have been increasingly linked to disordered astrocyte signalling within the cerebral cortex. We have recently demonstrated that the purinergic signalling pathway, which utilizes nucleoside triphosphates and their metabolites to facilitate bidirectional glial and glial-neuronal interactions, is upregulated in cortical astrocytes derived from the Fmr1 knockout (KO) mouse model of FXS. Heightened Fmr1 KO P2Y purinergic receptor levels were correlated with prolonged intracellular calcium release, elevated synaptogenic protein secretion, and hyperactivity of developing circuits. However, due to the relative lack of sensitive and reproducible quantification methods available for measuring purines and pyrimidines, determining the abundance of these factors in Fmr1 KO astrocytes was limited. We therefore developed a hydrophilic interaction liquid chromatography protocol coupled with mass spectrometry to compare the abundance of intracellular and extracellular purinergic molecules between wildtype and Fmr1 KO mouse astrocytes. Significant differences in the concentrations of UDP, ATP, AMP, and adenosine intracellular stores were found within Fmr1 KO astrocytes relative to WT. The extracellular level of adenosine was also significantly elevated in Fmr1 KO astrocyte-conditioned media in comparison to media collected from WT astrocytes. Glycosylation of the astrocyte membrane-bound CD39 ectonucleotidase, which facilitates ligand breakdown following synaptic release, was also elevated in Fmr1 KO astrocyte cultures. Together, these differences demonstrated further dysregulation of the purinergic signalling system within Fmr1 KO cortical astrocytes, potentially leading to significant alterations in FXS purinergic receptor activation and cellular pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Crystallographic insight into the binding modes of group 12 metal cations with N7-alkylated purines.
- Author
-
Panda, Subhra Jyoti, Agrawalla, Suraj Kumar, and Purohit, Chandra Shekhar
- Subjects
- *
HYDROGEN bonding interactions , *LINEAR polymers , *METAL ions , *PURINES , *STACKING interactions - Abstract
This study explores the complexation behavior of previously unexplored N7-alkylated 6-chloropurine derivatives with group 12 metal cations (Zn2+, Cd2+, and Hg2+), where N9 is free to coordinate. Notably, with high basicity, the N9 nitrogen atoms serve as the primary coordination sites for all investigated metal ions. The N1 position does not coordinate with any metal ions under this study. Interestingly, N3 participates in binding with Cd2+ and Hg2+ ions, resulting in the formation of a 1D linear coordination polymer bridged by chloride anions. The observed polymeric structure exhibits further extension through intermolecular non-classical hydrogen bonding and π–π stacking interactions. In contrast, Zn2+ forms discrete coordination complexes that extend in the lattice due to hydrogen bonding interactions. The observed consistency in coordination preferences of metal–purine complexes translates to predictable motifs, and this reliable binding can serve as a synthon for the targeted construction of MOFs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Reconstructive Approach to the Regiospecific Synthesis of N9‐Alkylated Purines.
- Author
-
Savateev, Konstantin V., Gazizov, Denis A., Slepukhin, Pavel A., Ulomsky, Evgeniy N., and Rusinov, Vladimir L.
- Subjects
- *
PALLADIUM catalysts , *GROUP 15 elements , *PURINES , *NUCLEOSIDES , *TAUTOMERISM - Abstract
A regiospecific synthesis of N9‐alkylated purines as novel acyclic nucleosides was developed. This approach is based on reconstructive methodology involving the construction of a target heterocyclic scaffold on a readily available 5‐aminotetrazole moiety, which is subsequently cleaved under reductive conditions due to azido‐tetrazole tautomerism. It appeared that the rate of reduction for the azide fragment in 6‐nitro‐7‐alkylaminotetrazolo[1,5‐a]pyrimidines is much greater than the rate of nitro group reduction. Treatment of these heterocycles with hydrogen over a palladium catalyst resulted in the formation of triaminopyrimidines in excellent yields through the reduction of both the azide and nitro group. Triaminopyrimidines were transformed into the desired N9‐alkylated purines, and an analog of the marketed drug penciclovir was synthesized by the developed method. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Use of homeopathy in feeding piglets as an alternative to reduce fighting behavior in the nursery phase: effects on production and hematological, metabolic, and oxidative variables.
- Author
-
Zago, Isadora, Galli, Gabriela M., Ficagna, Cássio A., Zatti, Emerson, Tarasconi, Lara, D'Vitt, Maksuel G., Paiano, Diovani, and da Silva, Aleksandro S.
- Subjects
- *
HOMEOPATHIC agents , *CENTRAL nervous system , *CEREBRAL cortex , *WEIGHT gain , *WELL-being - Abstract
This study aimed to determine whether using a homeopathic agent would improve the behavior, growth performance, redox status, and neuroimmune pathways of the central nervous system in weaned pigs. A total of 108 pigs in the nursery phase were divided into four groups with nine replicates per group (n = 3) as follows: the negative control (NC) group, receiving only the basal diet, the HC2.5 group treated with a conventional and commercial homeopathic at 2.5 kg/t in the basal diet (the vehicle was CaCO3), the HT2.5 group treated with a homeopathic test at 2.5 kg/t in the basal diet (expanded silicate vehicle), and the HT5 group treated with a homeopathic at 5 kg/t in the basal diet (expanded silicate vehicle). It was verified that in the HT5 group, followed by the HC2.5 group, the pigs spent less time standing still compared to the NC group (P = 0.001), and the pigs in the HT2.5 group spent less time sleeping than the NC and HT5 groups (P = 0.024). A higher villus-to-crypt ratio was found in the HT5 group than in others (P = 0.01). In the cerebellum, a lower activity of 5′-nucleotidase/adenosine monophosphate was observed in all groups that received the homeopathic compared to the NC group (P = 0.01). In the cerebral cortex, there was a lower activity of the enzymes NTPDase/ATP, NTPDase/ADP, and 5′-nucleotidase/AMP in all groups that received homeopathic treatment compared to the NC group. During growing, there was greater weight gain in pigs that received the homeopathic concerning NC (P = 0.02), as the pigs had a lower incidence of fighting behavior. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Biosynthesis and signal transduction of plant growth regulators and their effects on bioactive compound production in Salvia miltiorrhiza (Danshen).
- Author
-
Li, Heqin, Jiang, Xuwen, Mashiguchi, Kiyoshi, Yamaguchi, Shinjiro, and Lu, Shanfa
- Subjects
- *
HYDROCARBON analysis , *NITRIC oxide analysis , *AMINE analysis , *CHINESE medicine , *CARDIOVASCULAR diseases , *HERBAL medicine , *GENETIC engineering , *ETHYLENE , *CELLULAR signal transduction , *TRANSCRIPTION factors , *PLANT extracts , *METABOLITES , *INDOLE compounds , *CARBOCYCLIC acids , *GROWTH factors , *MOLECULAR structure , *MEDICINAL plants , *PURINES , *SALICYLIC acid , *ORGANIC compounds , *CEREBROVASCULAR disease - Abstract
Plant growth regulators (PGRs) are involved in multiple aspects of plant life, including plant growth, development, and response to environmental stimuli. They are also vital for the formation of secondary metabolites in various plants. Salvia miltiorrhiza is a famous herbal medicine and has been used commonly for > 2000 years in China, as well as widely used in many other countries. S. miltiorrhiza is extensively used to treat cardiovascular and cerebrovascular diseases in clinical practices and has specific merit against various diseases. Owing to its outstanding medicinal and commercial potential, S. miltiorrhiza has been extensively investigated as an ideal model system for medicinal plant biology. Tanshinones and phenolic acids are primary pharmacological constituents of S. miltiorrhiza. As the growing market for S. miltiorrhiza, the enhancement of its bioactive compounds has become a research hotspot. S. miltiorrhiza exhibits a significant response to various PGRs in the production of phenolic acids and tanshinones. Here, we briefly review the biosynthesis and signal transduction of PGRs in plants. The effects and mechanisms of PGRs on bioactive compound production in S. miltiorrhiza are systematically summarized and future research is discussed. This article provides a scientific basis for further research, cultivation, and metabolic engineering in S. miltiorrhiza. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Integrated network pharmacology and metabolomics to reveal the mechanism of Pinellia ternata inhibiting non-small cell lung cancer cells.
- Author
-
Feng, Fan, Hu, Ping, Peng, Lei, Xu, Lisheng, Chen, Jun, Chen, Qiong, Zhang, Xingtao, and Tao, Xingkui
- Subjects
THERAPEUTIC use of antineoplastic agents ,CELL migration inhibition ,WOUND healing ,HIGH performance liquid chromatography ,RESEARCH funding ,CANCER invasiveness ,LIQUID chromatography-mass spectrometry ,T-test (Statistics) ,DATA analysis ,PHARMACEUTICAL chemistry ,CELL proliferation ,UNIVERSITIES & colleges ,VITAMIN B2 ,MULTIVARIATE analysis ,PLANT extracts ,CELL lines ,METABOLITES ,GENE expression ,ENERGY metabolism ,EXPERIMENTAL design ,CELL culture ,MEDICINAL plants ,METABOLISM ,PURINES ,WESTERN immunoblotting ,STATISTICS ,ONE-way analysis of variance ,LUNG cancer ,METABOLOMICS ,ORGANIC compounds ,CELL survival ,BIOLOGICAL assay ,DATA analysis software - Abstract
Lung cancer is a malignant tumor with highly heterogeneous characteristics. A classic Chinese medicine, Pinellia ternata (PT), was shown to exert therapeutic effects on lung cancer cells. However, its chemical and pharmacological profiles are not yet understood. In the present study, we aimed to reveal the mechanism of PT in treating lung cancer cells through metabolomics and network pharmacology. Metabolomic analysis of two strains of lung cancer cells treated with Pinellia ternata extracts (PTE) was used to identify differentially abundant metabolites, and the metabolic pathways associated with the DEGs were identified by MetaboAnalyst. Then, network pharmacology was applied to identify potential targets against PTE-induced lung cancer cells. The integrated network of metabolomics and network pharmacology was constructed based on Cytoscape. PTE obviously inhibited the proliferation, migration and invasion of A549 and NCI-H460 cells. The results of the cellular metabolomics analysis showed that 30 metabolites were differentially expressed in the lung cancer cells of the experimental and control groups. Through pathway enrichment analysis, 5 metabolites were found to be involved in purine metabolism, riboflavin metabolism and the pentose phosphate pathway, including D-ribose 5-phosphate, xanthosine, 5-amino-4-imidazolecarboxyamide, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Combined with network pharmacology, 11 bioactive compounds were found in PT, and networks of bioactive compound–target gene–metabolic enzyme–metabolite interactions were constructed. In conclusion, this study revealed the complicated mechanisms of PT against lung cancer. Our work provides a novel paradigm for identifying the potential mechanisms underlying the pharmacological effects of natural compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. The Painful Malady of Gout.
- Author
-
Schreiber, Mary L.
- Subjects
- *
GOUT diagnosis , *CONTINUING education units , *BEHAVIOR modification , *DISEASE management , *HYPERURICEMIA , *CHRONIC diseases , *GOUT , *URIC acid , *HEALTH behavior , *PURINES , *QUALITY of life , *FOOD preferences , *WOMEN'S health , *DIET , *NUTRITION , *DISEASE complications , *SYMPTOMS - Abstract
Gout is a debilitating form of inflammatory arthritis resulting from high serum urate. Close monitoring of serum urate, medications, and specific dietary choices are required for successful management, including a commitment to regular medical examinations and lifestyle modifications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer.
- Author
-
Chakraborty, Nishma, Matulionis, Nedas, Hernandez, Stephanie, Ueno, Daiki, Gee, Michayla, Esplin, Edward, Ouyang, Karen, Nykamp, Keith, Shuch, Brian, Christofk, Heather, and Wilde, Blake
- Subjects
Humans ,Fumarate Hydratase ,Virulence ,Carcinoma ,Renal Cell ,Kidney Neoplasms ,Skin Neoplasms ,Purines - Abstract
UNLABELLED: Fumarate accumulation due to loss of fumarate hydratase (FH) drives cellular transformation. Germline FH alterations lead to hereditary leiomyomatosis and renal cell cancer (HLRCC) where patients are predisposed to an aggressive form of kidney cancer. There is an unmet need to classify FH variants by cancer-associated risk. We quantified catalytic efficiencies of 74 variants of uncertain significance. Over half were enzymatically inactive, which is strong evidence of pathogenicity. We next generated a panel of HLRCC cell lines expressing FH variants with a range of catalytic activities, then correlated fumarate levels with metabolic features. We found that fumarate accumulation blocks de novo purine biosynthesis, rendering FH-deficient cells reliant on purine salvage for proliferation. Genetic or pharmacologic inhibition of the purine salvage pathway reduced HLRCC tumor growth in vivo. These findings suggest the pathogenicity of patient-associated FH variants and reveal purine salvage as a targetable vulnerability in FH-deficient tumors. SIGNIFICANCE: This study functionally characterizes patient-associated FH variants with unknown significance for pathogenicity. This study also reveals nucleotide salvage pathways as a targetable feature of FH-deficient cancers, which are shown to be sensitive to the purine salvage pathway inhibitor 6-mercaptopurine. This presents a new rapidly translatable treatment strategy for FH-deficient cancers. This article is featured in Selected Articles from This Issue, p. 1949.
- Published
- 2023
10. Unexpected products of the reaction of purine nucleic base perchlorates with acetylacetone causing single-strand breaks in the DNA molecule.
- Author
-
Zdereva, Polina S., Bezhenar, Grigorii V., Sokolova, Anastasiya N., Paponov, Boris V., Rumyantsev, Andrey M., Sambuk, Elena V., Maistrenko, Dmitry N., and Molchanov, Oleg E.
- Subjects
- *
SINGLE-strand DNA breaks , *FORMIC acid , *CHEMICAL synthesis , *PERCHLORATES , *ACETYLACETONE - Abstract
The reactions of purine nucleic base perchlorates with the simplest 1,3-diketone – acetylacetone – were studied for the first time. It was demonstrated that adenine reacts with acetylacetone in a 1:2 molar ratio via opening of the pyrimidine fragment of the bicyclic struc- ture, elimination of a one-carbon fragment in the form of a formic acid molecule, and recyclization into 8-(4,6-dimethylpyrimidin-2-yl)- 2,4-dimethylimidazo[1,5-a]pyrimidine. Guanine, in turn, reacted with acetylacetone in a 1:1 ratio and formed 7,9-dimethyl-3H-pyrimido- [2,1-b]purin-10-ium-4-olate. In this case, the direction of heterocyclization differed from that observed in the reaction of guanine with malondialdehyde during the in vitro and in vivo formation of the minor nucleotide base M1G. The synthesized compounds were capable of causing single-strand breaks in DNA macromolecules. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives.
- Author
-
Areias, Filipe, Correia, Carla, Rocha, Ashly, Teixeira, Sofia, Castro, Marián, Brea, Jose, Hu, Huabin, Carlsson, Jens, Loza, Maria I., Proença, M. Fernanda, and Carvalho, M. Alice
- Subjects
- *
ADENOSINE derivatives , *ADENOSINES , *RADIOLIGAND assay , *STRUCTURE-activity relationships , *G protein coupled receptors , *PURINES - Abstract
A set of 2-aryl-9-H or methyl-6-morpholinopurine derivatives were synthesized and assayed through radioligand binding tests at human A1, A2A, A2B, and A3 adenosine receptor subtypes. Eleven purines showed potent antagonism at A1, A3, dual A1/A2A, A1/A2B, or A1/A3 adenosine receptors. Additionally, three compounds showed high affinity without selectivity for any specific adenosine receptor. The structure-activity relationships were made for this group of new compounds. The 9-methylpurine derivatives were generally less potent but more selective, and the 9H-purine derivatives were more potent but less selective. These compounds can be an important source of new biochemical tools and/or pharmacological drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Assessment of DNA/RNA Deregulation in Cancer Using 99mTc-Labeled Thiopurine.
- Author
-
Chiu, Chuang-Hsin, Yang, David J., Liou, Yi-Chen, Chang, Wei-Chung, Yu, Tsung-Hsun, Chung, Min-Ching, Lee, Yen-Chun, Chen, Ing-Jou, Wang, Pao-Yeh, Lin, Ching-Po, Tsay, Hey-Jen, and Yeh, Skye Hsin-Hsien
- Subjects
- *
RNA metabolism , *DNA metabolism , *IN vitro studies , *RADIOPHARMACEUTICALS , *T-test (Statistics) , *STATISTICAL significance , *RESEARCH funding , *OVARIAN tumors , *BREAST tumors , *CHELATING agents , *APOPTOSIS , *DEOXY sugars , *EPIGENOMICS , *IN vivo studies , *IMMUNODIAGNOSIS , *CELL cycle , *MICE , *PURINES , *ANIMAL experimentation , *MOLECULAR structure , *TUMORS , *DATA analysis software , *CELL surface antigens - Abstract
Background: DNA biomarkers are useful for the assessment of tumor cell proliferation. The authors aimed to synthesize a thiopurine-based ligand for evaluation of nuclear uptake and tumor localization. Materials and Methods: A 2-hydroxypropyl spacer was incorporated between a chelator (cyclam) and thiopurine ligand to produce SC-06-L1. In vitro cellular uptake and the cell/media ratios of [99mTc]Tc-SC-06-L1 were assessed in breast (MCF-7, MDA-MB-231) and ovarian (TOV-112D, OVCAR3) cancer cells. The nuclear and cytosolic uptake ratio of [99mTc]Tc-SC-06-L1 was determined in OVCAR-3 and MCF-7 cells. Cytotoxicity assays and flow cytometric analysis of cell cycle apoptosis were conducted in cancer cells treated with SC-06-L1. Imaging was conducted in tumor-bearing mice; fluorine-18-2′-fluorodeoxyglucose ([18F]FDG) was used as a control. Results: The radiochemical purity of [99mTc]Tc-SC-06-L1 was >95%. [99mTc]Tc-SC-06-L1 exhibited higher cell-to-media ratios than [18F]FDG in cancer cells. [99mTc]Tc-SC-06-L1 had high uptake in the nuclear fractions in OVCAR-3 and MCF-7 cells, with nuclear/cytosolic ratios of 8 and 2, respectively. Cytotoxicity assays showed that SC-06-L1 was non-toxic compared with azathioprine in breast and ovarian cancer cells. Conclusions: [99mTc]Tc-SC-06-L1 was stable and involved in nuclear activities. [99mTc]Tc-SC-06-L1 showed non-toxic to cancer cells and exhibited fast kinetic uptake patterns for tumor imaging. [99mTc]Tc-SC-06-L1 represents a promising biomarker for imaging purine pathway-directed systems. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Hypoxanthine Induces Signs of Bladder Aging With Voiding Dysfunction and Lower Urinary Tract Remodeling.
- Author
-
Birder, Lori A, Wolf-Johnston, Amanda S, Zabbarova, Irina, Ikeda, Youko, Robertson, Anne M, Cardozo, Ricardo, Azari, Fatemeh, Kanai, Anthony J, Kuchel, George A, and Jackson, Edwin K
- Subjects
- *
URINARY organs , *URINATION disorders , *BLADDER , *URINARY stress incontinence , *URINARY incontinence , *HYPOXANTHINE - Abstract
Background Lower urinary tract syndrome (LUTS) is a group of urinary tract symptoms and signs that can include urinary incontinence. Advancing age is a major risk factor for LUTS; however, the underlying biochemical mechanisms of age-related LUTS remain unknown. Hypoxanthine (HX) is a purine metabolite associated with generation of tissue-damaging reactive oxygen species (ROS). This study tested the hypothesis that exposure of the adult bladder to HX–ROS over time damages key LUT elements, mimicking qualitatively some of the changes observed with aging. Methods Adult 3-month-old female Fischer 344 rats were treated with vehicle or HX (10 mg/kg/day; 3 weeks) administered in drinking water. Targeted purine metabolomics and molecular approaches were used to assess purine metabolites and biomarkers for oxidative stress and cellular damage. Biomechanical approaches assessed LUT structure and measurements of LUT function (using custom-metabolic cages and cystometry) were also employed. Results HX exposure increased biomarkers indicative of oxidative stress, pathophysiological ROS production, and depletion of cellular energy with declines in NAD+ levels. Moreover, HX treatment caused bladder remodeling and decreased the intercontraction interval and leak point pressure (surrogate measure to assess stress urinary incontinence). Conclusions These studies provide evidence that in adult rats chronic exposure to HX causes changes in voiding behavior and in bladder structure resembling alterations observed with aging. These results suggest that increased levels of uro-damaging HX were associated with ROS/oxidative stress-associated cellular damage, which may be central to age-associated development of LUTS, opening up potential opportunities for geroscience-guided interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Hubungan Konsumsi Purin dan Hipertensi terhadap Serangan Berulang Atritis Gout pada Pasien di Puskesmas Kecamatan Krembangan pada Tahun 2022.
- Author
-
Crisantika, Eucharistia, Sintia, Nely, and Wahyuni, Chatarina Umbul
- Subjects
WORK ,LABOR productivity ,DATA analysis ,HYPERTENSION ,SCIENTIFIC observation ,JUDGMENT sampling ,DESCRIPTIVE statistics ,GOUT ,ARTHRITIS ,PURINES ,QUALITY of life ,CASE-control method ,STATISTICS - Published
- 2024
- Full Text
- View/download PDF
15. Nitrogen-Centered Radicals Derived from Azidonucleosides.
- Author
-
Reyes, Yahaira, Adhikary, Amitava, and Wnuk, Stanislaw F.
- Subjects
- *
RADICALS (Chemistry) , *BIOCHEMISTRY , *PYRIMIDINE nucleotides , *AZIDO group , *CLICK chemistry , *RIBONUCLEOSIDE diphosphate reductase - Abstract
Azido-modified nucleosides have been extensively explored as substrates for click chemistry and the metabolic labeling of DNA and RNA. These compounds are also of interest as precursors for further synthetic elaboration and as therapeutic agents. This review discusses the chemistry of azidonucleosides related to the generation of nitrogen-centered radicals (NCRs) from the azido groups that are selectively inserted into the nucleoside frame along with the subsequent chemistry and biological implications of NCRs. For instance, the critical role of the sulfinylimine radical generated during inhibition of ribonucleotide reductases by 2′-azido-2′-deoxy pyrimidine nucleotides as well as the NCRs generated from azidonucleosides by radiation-produced (prehydrated and aqueous) electrons are discussed. Regio and stereoselectivity of incorporation of an azido group ("radical arm") into the frame of nucleoside and selective generation of NCRs under reductive conditions, which often produce the same radical species that are observed upon ionization events due to radiation and/or other oxidative conditions that are emphasized. NCRs generated from nucleoside-modified precursors other than azidonucleosides are also discussed but only with the direct relation to the same/similar NCRs derived from azidonucleosides. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. The anti-hyperuricemic and gut microbiota regulatory effects of a novel purine assimilatory strain, Lactiplantibacillus plantarum X7022.
- Author
-
Zou, Yuan, Ro, Kum-Song, Jiang, Chentian, Yin, Deyi, Zhao, Li, Zhang, Daihui, Du, Lei, and Xie, Jingli
- Subjects
- *
INFLAMMATION prevention , *FECAL analysis , *HIGH performance liquid chromatography , *BIOLOGICAL models , *CREATININE , *SHORT-chain fatty acids , *PROPIONATES , *RESEARCH funding , *GUT microbiome , *POLYMERASE chain reaction , *HYPERURICEMIA , *IN vivo studies , *BLOOD urea nitrogen , *DNA , *VITAMIN B complex , *MESSENGER RNA , *GENE expression , *MICE , *PURINES , *ANIMAL experimentation , *URIC acid , *WESTERN immunoblotting , *PROBIOTICS , *BUTYRIC acid , *GRAM-positive bacteria , *SEQUENCE analysis , *XANTHINE - Abstract
Purpose: Probiotics have been reported to effectively alleviate hyperuricemia and regulate the gut microbiota. The aim of this work was to study the in vivo anti-hyperuricemic properties and the mechanism of a novel strain, Lactiplantibacillus plantarum X7022. Methods: Purine content and mRNA expression of purine assimilation related enzymes were determined by HPLC and qPCR, respectively. Hyperuricemic mice were induced by potassium oxonate and hypoxanthine. Uric acid (UA), blood urea nitrogen, creatinine and renal inflammation were examined by kits. The expression of renal UA transporters was subjected to western blotting. Kidney tissues were sectioned for histological analysis. The fecal short-chain fatty acids (SCFAs) were determined by HPLC, and gut microbiota was investigated using the 16S rDNA metagenomic sequencing. Results: L. plantarum X7022 possesses a complete purine assimilation pathway and can exhaust xanthine, guanine, and adenine by 82.1%, 33.1%, and 12.6%, respectively. The strain exhibited gastrointestinal viability as 44% at the dose of 109 CFU/mL in mice. After four-week administration of the strain, a significant decrease of 35.5% in the serum UA level in hyperuricemic mice was achieved. The diminished contents of fecal propionate and butyrate were dramatically boosted. The treatment also alleviated renal inflammation and restored renal damage. The above physiological changes may due to the inhibited xanthine oxidase (XO) activity, as well as the expressional regulation of UA transporters (GLUT9, URAT1 and OAT1) to the normal level. Notably, gut microbiota dysbiosis in hyperuricemic mice was improved with the inflammation and hyperuricemia related flora depressed, and SCFAs production related flora promoted. Conclusion: The strain is a promising probiotic strain for ameliorating hyperuricemia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Evaluation on purine metabolism in human skin fibroblast cells exposed to oxygenated polycyclic aromatic hydrocarbons.
- Author
-
Liu, Junqi, Wang, Saijin, Wang, Meng, Li, Zan, Zhou, Shi, Li, Jinlian, and Wu, Dongmei
- Subjects
- *
POLYCYCLIC aromatic hydrocarbons , *HIGH performance liquid chromatography , *PERSISTENT pollutants , *FIBROBLASTS , *CELL metabolism , *CYTOTOXINS , *ADENINE - Abstract
A rapid and sensitive assessment of the toxicity of oxygenated polycyclic aromatic hydrocarbons (OPAHs), widely distributed persistent organic pollutants in the environment, is crucial for human health. In this study, using high-performance liquid chromatography, the separation and detection of four purines, xanthine (X), guanine (G), adenine (A), and hypoxanthine (HX) in cells were performed. The aim was to evaluate the cytotoxicity of three OPAHs, namely 1,4-benzoquinone (1,4-BQ), 1,2-naphthoquinone (1,2-NQ) and 9,10-phenanthrenequinone (9,10-PQ), with higher environmental concentrations, from the perspective of purine nucleotide metabolism in human skin fibroblast cells (HFF-1). The results revealed that the levels of G and A were low in HFF-1 cells, while the levels of HX and X showed a dose-response relationship with persistent organic pollutants concentration. With increased concentration of the three persistent organic pollutants, the purine metabolism in HFF-1 cells weakened, and the impact of the three persistent organic pollutants on purine metabolism in cells was in the order of 9,10-PQ > 1,4-BQ > 1,2-NQ. This study provided valuable insights into the toxic mechanisms of 1,4-BQ, 1,2-NQ and 9,10-PQ, contributing to the formulation of relevant protective measures and the safeguarding of human health. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. MGMT Methylation and Differential Survival Impact by Sex in Glioblastoma.
- Author
-
Barnett, Addison E., Ozair, Ahmad, Bamashmos, Anas S., Li, Hong, Bosler, David S., Yeaney, Gabrielle, Ali, Assad, Peereboom, David M., Lathia, Justin D., and Ahluwalia, Manmeet S.
- Subjects
- *
METHYLATION , *DNA methyltransferases , *GLIOMAS , *RESEARCH funding , *SEX distribution , *PHOSPHATES , *PROBABILITY theory , *CYSTEINE , *DESCRIPTIVE statistics , *PROMOTERS (Genetics) , *RETROSPECTIVE studies , *GENETIC polymorphisms , *LONGITUDINAL method , *KAPLAN-Meier estimator , *MOLECULAR structure , *PURINES , *STATISTICS , *SURVIVAL analysis (Biometry) , *CONFIDENCE intervals , *PROPORTIONAL hazards models , *OVERALL survival - Abstract
Simple Summary: Glioblastoma is a highly aggressive and lethal brain tumor that has seen marginal improvement in patient outcomes despite decades of concerted efforts. This study investigated the impact of tumor molecular features, sex, and their interaction on the survival of patients with newly diagnosed glioblastoma. Our findings show that females are more often found to have silencing of the MGMT promoter, but that they also receive a greater survival benefit, which is more clinically and statistically significant, associated with MGMT promoter silencing that is not reflected in males. These findings may significantly impact both our understanding as well as the clinical management of the disease. Rather than the established practice of using temozolomide to treat MGMT promoter methylated patients as a whole, our findings suggest that females accrue a disproportionate survival benefit compared to males who, regardless of methylation status, may experience better survival outcomes from alternative treatment options. Introduction: Sex differences in glioblastoma (GBM) have been observed in incidence, genetic and epigenetic alterations, and immune response. These differences have extended to the methylation of the MGMT promoter, which critically impacts temozolomide resistance. However, the association between sex, MGMT methylation, and survival is poorly understood, which this study sought to evaluate. Methods: A retrospective cohort study was conducted and reported following STROBE guidelines, based on adults with newly diagnosed GBM who received their first surgical intervention at Cleveland Clinic (Ohio, USA) between 2012 and 2018. Kaplan–Meier and multivariable Cox proportional hazards models were used to analyze the association between sex and MGMT promoter methylation status on overall survival (OS). MGMT was defined as methylated if the mean of CpG 1-5 ≥ 12. Propensity score matching was performed on a subset of patients to evaluate the effect of individual CpG site methylation. Results: A total of 464 patients had documented MGMT methylation status with a mean age of 63.4 (range 19–93) years. A total of 170 (36.6%) were female, and 133 (28.7%) received gross total resection as a first intervention. A total of 42.5% were MGMT methylated, with females more often having MGMT methylation than males (52.1% vs. 37.4%, p = 0.004). In univariable analysis, OS was significantly longer for MGMT promoter methylated than un-methylated groups for females (2 yr: 36.8% vs. 11.1%; median: 18.7 vs. 9.5 months; p = 0.001) but not for males (2 yr: 24.3% vs. 12.2%; median: 12.4 vs. 11.3 months; p = 0.22, p for MGMT–sex interaction = 0.02). In multivariable analysis, MGMT un-methylated versus methylated promoter females (2.07; 95% CI, 1.45–2.95; p < 0.0001) and males (1.51; 95% CI, 1.14–2.00; p = 0.004) had worse OS. Within the MGMT promoter methylated group, males had significantly worse OS than females (1.42; 95% CI: 1.01–1.99; p = 0.04). Amongst patients with data on MGMT CpG promoter site methylation values (n = 304), the median (IQR) of CpG mean methylation was 3.0% (2.0, 30.5). Females had greater mean CpG methylation than males (11.0 vs. 3.0, p < 0.002) and higher per-site CpG methylation with a significant difference at CPG 1, 2, and 4 (p < 0.008). After propensity score matching, females maintained a significant survival benefit (18.7 vs. 10.0 months, p = 0.004) compared to males (13.0 vs. 13.6 months, p = 0.76), and the pattern of difference was significant (P for CpG–sex interaction = 0.03). Conclusions: In this study, females had higher mean and individual CpG site methylation and received a greater PFS and OS benefit by MGMT methylation that was not seen in males despite equal degrees of CpG methylation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients.
- Author
-
Mangione, Renata, Giallongo, Cesarina, Duminuco, Andrea, La Spina, Enrico, Longhitano, Lucia, Giallongo, Sebastiano, Tibullo, Daniele, Lazzarino, Giuseppe, Saab, Miriam Wissam, Sbriglione, Arianna, Palumbo, Giuseppe A., Graziani, Andrea, Alanazi, Amer M., Di Pietro, Valentina, Tavazzi, Barbara, Amorini, Angela Maria, and Lazzarino, Giacomo
- Subjects
PYRIMIDINES ,MYELOFIBROSIS ,ENERGY metabolism ,MALONDIALDEHYDE ,METABOLOMICS ,VITAMIN C ,URIC acid ,OXIDANT status - Abstract
To date, little is known concerning the circulating levels of biochemically relevant metabolites (antioxidants, oxidative/nitrosative stress biomarkers, purines, and pyrimidines) in patients with primary myelofibrosis (PMF), a rare form of myeloproliferative tumor causing a dramatic decrease in erythropoiesis and angiogenesis. In this study, using a targeted metabolomic approach, serum samples of 22 PMF patients and of 22 control healthy donors were analyzed to quantify the circulating concentrations of hypoxanthine, xanthine, uric acid (as representative purines), uracil, β-pseudouridine, uridine (as representative pyrimidines), reduced glutathione (GSH), ascorbic acid (as two of the main water-soluble antioxidants), malondialdehyde, nitrite, nitrate (as oxidative/nitrosative stress biomarkers) and creatinine, using well-established HPLC method for their determination. Results showed that PMF patients have dramatic depletions of both ascorbic acid and GSH (37.3- and 3.81-times lower circulating concentrations, respectively, than those recorded in healthy controls, p < 0.0001), accompanied by significant increases in malondialdehyde (MDA) and nitrite + nitrate (4.73- and 1.66-times higher circulating concentrations, respectively, than those recorded in healthy controls, p < 0.0001). Additionally, PMF patients have remarkable alterations of circulating purines, pyrimidines, and creatinine, suggesting potential mitochondrial dysfunctions causing energy metabolism imbalance and consequent increases in these cell energy-related compounds. Overall, these results, besides evidencing previously unknown serum metabolic alterations in PMF patients, suggest that the determination of serum levels of the aforementioned compounds may be useful to evaluate PMF patients on hospital admission for adjunctive therapies aimed at recovering their correct antioxidant status, as well as to monitor patients' status and potential pharmacological treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Purinergic exposure induces epigenomic and transcriptomic-mediated preconditioning resembling epilepsy-associated microglial states
- Author
-
Ricardo Martins-Ferreira, Josep Calafell-Segura, João Chaves, Laura Ciudad, António Martins da Silva, Paulo Pinho e Costa, Bárbara Leal, and Esteban Ballestar
- Subjects
Microglia ,Purines ,Epilepsy ,Epigenetics ,Transcriptomics ,Science - Abstract
Summary: Microglia play a crucial role in a range of neuropathologies through exacerbated activation. Microglial inflammatory responses can be influenced by prior exposures to noxious stimuli, like increased levels of extracellular adenosine and ATP. These are characteristic of brain insults like epileptic seizures and could potentially shape subsequent responses through epigenetic regulation. We investigated DNA methylation and expression changes in human microglia-like cells differentiated from monocytes following ATP-mediated preconditioning. We demonstrate that microglia-like cells display homeostatic microglial features, shown by surface markers, transcriptome, and DNA methylome. After exposure to ATP, TLR-mediated activation leads to an exacerbated pro-inflammatory response. These changes are accompanied by methylation and transcriptional reprogramming associated with enhanced immune-related functions. The reprogramming associated with ATP-mediated preconditioning leads to profiles found in microglial subsets linked to epilepsy. Purine-driven microglia immune preconditioning drives epigenetic and transcriptional changes that could contribute to altered functions of microglia during seizure development and progression.
- Published
- 2024
- Full Text
- View/download PDF
21. Thrifty tissues prefer recycled purines over new-cleotides.
- Author
-
Sokolov, David and Sullivan, Lucas B.
- Subjects
- *
PURINES , *CELL metabolism , *TUMOR growth , *TISSUES - Abstract
In two recent studies appearing in Cell 1 and Cell Metabolism , 2 Tran et al. and Wu et al. describe underappreciated nuance in organismal and cellular purine nucleotide salvage pathways and identify purine salvage as a metabolic limitation for tumor growth. In two recent studies appearing in Cell and Cell Metabolism , Tran et al. and Wu et al. describe underappreciated nuance in organismal and cellular purine nucleotide salvage pathways and identify purine salvage as a metabolic limitation for tumor growth. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. eIF4A1-dependent mRNAs employ purine-rich 5’UTR sequences to activate localised eIF4A1-unwinding through eIF4A1-multimerisation to facilitate translation
- Author
-
Schmidt, Tobias, Dabrowska, Adrianna, Waldron, Joseph A, Hodge, Kelly, Koulouras, Grigorios, Gabrielsen, Mads, Munro, June, Tack, David C, Harris, Gemma, McGhee, Ewan, Scott, David, Carlin, Leo M, Huang, Danny, Le Quesne, John, Zanivan, Sara, Wilczynska, Ania, and Bushell, Martin
- Subjects
Genetics ,1.1 Normal biological development and functioning ,Underpinning research ,Generic health relevance ,Infection ,5' Untranslated Regions ,Protein Biosynthesis ,Purines ,RNA ,Messenger ,Humans ,Eukaryotic Initiation Factor-4A ,Environmental Sciences ,Biological Sciences ,Information and Computing Sciences ,Developmental Biology - Abstract
Altered eIF4A1 activity promotes translation of highly structured, eIF4A1-dependent oncogene mRNAs at root of oncogenic translational programmes. It remains unclear how these mRNAs recruit and activate eIF4A1 unwinding specifically to facilitate their preferential translation. Here, we show that single-stranded RNA sequence motifs specifically activate eIF4A1 unwinding allowing local RNA structural rearrangement and translation of eIF4A1-dependent mRNAs in cells. Our data demonstrate that eIF4A1-dependent mRNAs contain AG-rich motifs within their 5'UTR which specifically activate eIF4A1 unwinding of local RNA structure to facilitate translation. This mode of eIF4A1 regulation is used by mRNAs encoding components of mTORC-signalling and cell cycle progression, and renders these mRNAs particularly sensitive to eIF4A1-inhibition. Mechanistically, we show that binding of eIF4A1 to AG-rich sequences leads to multimerization of eIF4A1 with eIF4A1 subunits performing distinct enzymatic activities. Our structural data suggest that RNA-binding of multimeric eIF4A1 induces conformational changes in the RNA resulting in an optimal positioning of eIF4A1 proximal to the RNA duplex enabling efficient unwinding. Our data proposes a model in which AG-motifs in the 5'UTR of eIF4A1-dependent mRNAs specifically activate eIF4A1, enabling assembly of the helicase-competent multimeric eIF4A1 complex, and positioning these complexes proximal to stable localised RNA structure allowing ribosomal subunit scanning.
- Published
- 2023
23. Structural snapshots of base excision by the cancer-associated variant MutY N146S reveal a retaining mechanism
- Author
-
Demir, Merve, Russelburg, L Peyton, Lin, Wen-Jen, Trasviña-Arenas, Carlos H, Huang, Beili, Yuen, Philip K, Horvath, Martin P, and David, Sheila S
- Subjects
Inorganic Chemistry ,Biochemistry and Cell Biology ,Chemical Sciences ,Biological Sciences ,Genetics ,Colo-Rectal Cancer ,Digestive Diseases ,Cancer ,Humans ,Calcium ,DNA Repair ,Mutation ,Neoplasms ,Purines ,DNA Glycosylases ,Environmental Sciences ,Information and Computing Sciences ,Developmental Biology ,Biological sciences ,Chemical sciences ,Environmental sciences - Abstract
DNA glycosylase MutY plays a critical role in suppression of mutations resulted from oxidative damage, as highlighted by cancer-association of the human enzyme. MutY requires a highly conserved catalytic Asp residue for excision of adenines misinserted opposite 8-oxo-7,8-dihydroguanine (OG). A nearby Asn residue hydrogen bonds to the catalytic Asp in structures of MutY and its mutation to Ser is an inherited variant in human MUTYH associated with colorectal cancer. We captured structural snapshots of N146S Geobacillus stearothermophilus MutY bound to DNA containing a substrate, a transition state analog and enzyme-catalyzed abasic site products to provide insight into the base excision mechanism of MutY and the role of Asn. Surprisingly, despite the ability of N146S to excise adenine and purine (P) in vitro, albeit at slow rates, N146S-OG:P complex showed a calcium coordinated to the purine base altering its conformation to inhibit hydrolysis. We obtained crystal structures of N146S Gs MutY bound to its abasic site product by removing the calcium from crystals of N146S-OG:P complex to initiate catalysis in crystallo or by crystallization in the absence of calcium. The product structures of N146S feature enzyme-generated β-anomer abasic sites that support a retaining mechanism for MutY-catalyzed base excision.
- Published
- 2023
24. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis
- Author
-
Simpson, Eric L, Bissonnette, Robert, Paller, Amy S, King, Brett, Silverberg, Jonathan I, Reich, Kristian, Thyssen, Jacob P, Doll, Helen, Sun, Luna, DeLozier, Amy M, Nunes, Fabio P, and Eichenfield, Lawrence F
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Adult ,Azetidines ,Clinical Trials ,Phase III as Topic ,Dermatitis ,Atopic ,Humans ,Outcome Assessment ,Health Care ,Purines ,Pyrazoles ,Reproducibility of Results ,Severity of Illness Index ,Sulfonamides ,Oncology and Carcinogenesis ,Dermatology & Venereal Diseases ,Clinical sciences - Abstract
BackgroundThe validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™) is a standardized severity assessment for use in clinical trials and registries for atopic dermatitis (AD).ObjectivesTo investigate the reliability, validity, responsiveness and within-patient meaningful change of the vIGA-AD.MethodsData were analysed from adult patients with moderate-to-severe AD in the BREEZE-AD1 (N = 624 patients; NCT03334396), BREEZE-AD2 (N = 615; NCT03334422) and BREEZE-AD5 (N = 440; NCT03435081) phase III baricitinib clinical studies.ResultsAcross studies, test-retest reliability for stable patients showed moderate-to-good agreement [range of Kappa values for Patient Global Impression of Severity-Atopic Dermatitis (PGI-S-AD), 0·516-0·639; for Eczema Area and Severity Index (EASI), 0·658-0·778]. Moderate-to-large correlations between vIGA-AD and EASI or body surface area (range at baseline, 0·497-0·736; Week 16, 0·716-0·893) supported convergent validity. Known-groups validity was demonstrated vs. EASI and PGI-S-AD (vIGA-AD for severe vs. moderate EASI categories at baseline, P
- Published
- 2022
25. Metal-free, direct acylation of purines to access C6-acylated purine derivatives induced by TBHP via Minisci-type reaction.
- Author
-
Zou, Chunhui, Yu, Mingwu, Jiang, Zhongkai, Liu, Xiguang, Chen, Yiwen, and Zhang, Lele
- Subjects
- *
ACYLATION , *PURINES , *METAL catalysts , *RADICALS (Chemistry) , *FUNCTIONAL groups , *ALDEHYDES - Abstract
A metal-free C–H functionalization of purines with aldehydes was developed to access C6-acylated purines via green radical reactions. Theoretically, there are many competitive reactions due to the three C–H bonds (C2–H, C6–H, C8–H) in the purine, and the acylation only happens at the purinyl C6-position. This method avoids a metal catalyst and provides a green approach to construct C–C (sp2) bonds at the purinyl C6-position, while maintaining excellent compatibility with various functional groups. Moreover, the protocol features broad substrate scope and easy scale-up. The transformation of the product demonstrates the significant practical value of the method. The primary mechanism was proposed based on controlled experiments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. The function of chemical folic acid in calibration methods and neurodevelopmental disorders.
- Author
-
Ziqi Zhou, Meng Wang, Qiongli Fan, Yan Zhao, Nianrong Wang, Yujun Yang, Quan-Xing Liu, and Ayang Zhao
- Subjects
- *
FOLIC acid , *NEURAL development , *PURINES , *ADENINE , *COENZYMES - Abstract
Functional molecules have been attracting increasing attention in environmental and physiological studies. In particular, folic acid (FA) could be considered a key factor in estimating, adjusting, and making decisions in the treatment of neurodevelopmental disorders. It promotes the general significance and conceptual for considering FA molecular scientific research detections, which implies related advancement in both of biological structure and detection methods. Among these applications, the FA molecule acts as a coenzyme that incorporates carbon atoms and synthesizes purines and pyrimidines. Therefore, the calibration method has real applications and can be used as a sensing platform and for detection approaches, which conveys the internal relationship between the FA molecule and physiological characterization. This mini review briefly discusses multiple FA application fields and detection pathways and could supplement their utilization in anticipation of the onset of disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. The tautomer‐specific excited state dynamics of 2,6‐diaminopurine using resonance‐enhanced multiphoton ionization and quantum chemical calculations.
- Author
-
Gate, Gregory, Williams, Ann, Boldissar, Samuel, Šponer, Jiří, Szabla, Rafal, and de Vries, Mattanjah
- Subjects
- *
MULTIPHOTON ionization , *EXCITED states , *GAS dynamics , *INTRAMOLECULAR proton transfer reactions , *QUANTUM computing , *PURINES - Abstract
2,6‐Diaminopurine (2,6‐dAP) is an alternative nucleobase that potentially played a role in prebiotic chemistry. We studied its excited state dynamics in the gas phase by REMPI, IR‐UV hole burning, and ps pump‐probe spectroscopy and performed quantum chemical calculations at the SCS‐ADC(2) level of theory to interpret the experimental results. We found the 9H tautomer to have a small barrier to ultrafast relaxation via puckering of its 6‐membered ring. The 7H tautomer has a larger barrier to reach a conical intersection and also has a sizable triplet yield. These results are discussed relative to other purines, for which 9H tautomerization appears to be more photostable than 7H and homosubstituted purines appear to be less photostable than heterosubstituted or singly substituted purines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Clinical spectrum, biochemical profile and disease progression of Kennedy disease in an Indian cohort.
- Author
-
Baskar, Dipti, Veeramani‐Kumar, Preethish, Polavarapu, Kiran, Nashi, Saraswati, Vengalil, Seena, Menon, Deepak, Thomas, Aneesha, Bhargava Sanka, Sai, Muddasu Suhasini, Keerthipriya, Huddar, Akshata, Unnikrishnan, Gopikrishnan, Bardhan, Mainak, Thomas, Priya Treesa, Manjunath, Nisha, and Atchayaram, Nalini
- Subjects
- *
GYNECOMASTIA , *EXTREMITIES (Anatomy) , *FATIGUE (Physiology) , *X-linked bulbo-spinal atrophy , *RETROSPECTIVE studies , *MAGNETIC resonance imaging , *MUSCLE weakness , *TONGUE , *AMYOTROPHIC lateral sclerosis , *THIGH , *PURINES , *MUSCLE cramps , *PHENOTYPES , *GENETICS , *NERVE conduction studies , *SYMPTOMS - Abstract
Background: Kennedy disease (KD) is a slowly progressive lower motor neuron degenerative disease. The prevalence of KD is unknown in India. Aim: To describe the phenotypic and laboratory features of an Indian cohort of KD patients. Methods: A retrospective study was done on seven genetically confirmed KD patients based on demographic, clinical and laboratory details. Results: Mean age at onset and presentation was 37 ± 11.9 and 44.6 ± 13.5 years respectively. Progressive asymmetric proximal and distal limb weakness was the commonest symptom (57.1%). All patients had motor symptoms along with non‐specific symptoms such as cramps from the onset. Easy fatigability, decremental response along with ptosis were noted in two patients, which was a novel finding. Gynaecomastia and tongue wasting with fasciculations were universal findings. All five patients with nerve conduction studies showed sensorimotor neuropathy. Magnetic resonance imaging muscle done in two patients showed a prominent moth‐eaten appearance in the thigh and posterior leg compartment in one patient. The mean cytosine‐adenine‐guanine repeats were 44 ± 3.7, and there was no association between age of onset or severity with repeat length. Only one patient required an assistive device for ambulation after 15 years of symptom onset. Conclusions: This study showed phenotypic heterogeneity in the Indian cohort. The age of onset was earlier with a slowly progressive indolent course as compared with other ethnic cohorts. This highlights the importance of considering the KD diagnosis in patients with the indolent course and suspected ALS diagnosis even with ptosis and fatigability in an appropriate clinical context. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Allopurinol Disrupts Purine Metabolism to Increase Damage in Experimental Colitis.
- Author
-
Worledge, Corey S., Kostelecky, Rachael E., Zhou, Liheng, Bhagavatula, Geetha, Colgan, Sean P., and Lee, J. Scott
- Subjects
- *
WOUND healing , *INFLAMMATORY bowel diseases , *COLITIS , *ALLOPURINOL , *XANTHINE oxidase , *AMP-activated protein kinases - Abstract
Inflammatory bowel disease (IBD) is marked by a state of chronic energy deficiency that limits gut tissue wound healing. This energy shortfall is partially due to microbiota dysbiosis, resulting in the loss of microbiota-derived metabolites, which the epithelium relies on for energy procurement. The role of microbiota-sourced purines, such as hypoxanthine, as substrates salvaged by the colonic epithelium for nucleotide biogenesis and energy balance, has recently been appreciated for homeostasis and wound healing. Allopurinol, a synthetic hypoxanthine isomer commonly prescribed to treat excess uric acid in the blood, inhibits the degradation of hypoxanthine by xanthine oxidase, but also inhibits purine salvage. Although the use of allopurinol is common, studies regarding how allopurinol influences the gastrointestinal tract during colitis are largely nonexistent. In this work, a series of in vitro and in vivo experiments were performed to dissect the relationship between allopurinol, allopurinol metabolites, and colonic epithelial metabolism and function in health and during disease. Of particular significance, the in vivo investigation identified that a therapeutically relevant allopurinol dose shifts adenylate and creatine metabolism, leading to AMPK dysregulation and disrupted proliferation to attenuate wound healing and increased tissue damage in murine experimental colitis. Collectively, these findings underscore the importance of purine salvage on cellular metabolism and gut health in the context of IBD and provide insight regarding the use of allopurinol in patients with IBD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. 活性炭过滤对黄酒品质的影响.
- Author
-
谢铃, 刘双平, and 毛健
- Abstract
Copyright of Food & Fermentation Industries is the property of Food & Fermentation Industries and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
31. Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023).
- Author
-
Frange, P., Veber, F., Burgard, M., Blanche, S., and Avettand‐Fenoel, V.
- Subjects
- *
HIV infections , *HIV integrase inhibitors , *GENETIC mutation , *VIRAL load , *TENOFOVIR , *PURINES , *DRUG resistance , *RETROSPECTIVE studies , *ACQUISITION of data , *TREATMENT failure , *RISK assessment , *GENOTYPES , *MEDICAL records , *DRUGS , *PATIENT compliance , *EMTRICITABINE , *FRENCH people , *NUCLEOSIDE reverse transcriptase inhibitors , *CHILDREN , *ADOLESCENCE - Abstract
Objectives: Although widely recommended, data on bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) efficacy in HIV‐1‐infected children/adolescents are mainly extrapolated from studies in adults and one paediatric trial in which subjects have good treatment adherence. This study aimed to provide data about the risk of virological failure (VF) and acquired genotypic resistance in children and adolescents receiving BIC/FTC/TAF in a real‐world setting. Methods: This retrospective monocentric study included 74 paediatric patients who received BIC/FTC/TAF during ≥6 months in 2019–2023. VF was defined as not achieving a plasma viral load <50 copies/mL within 6 months of BIC/FTC/TAF initiation or as experiencing virological rebound ≥50 copies/mL. Results: Most patients were antiretroviral therapy (ART)‐experienced (93.2%), previously exposed to integrase inhibitors (85.1%) and displayed viral suppression at baseline (67.6%). Their median age was 11.2 years [interquartile range (IQR): 8.8–15.2]. BIC/FTC/TAF introduction reduced treatment burden in most ART‐experienced subjects. Genotypic susceptibility score of BIC/FTC/TAF was ≥2 in all cases. Median follow‐up was 40 months (IQR: 21–46). VF occurred in 28 people (37.8%), more frequently in the case of VF versus viral suppression at baseline (68% vs. 26%, P = 0.02). BIC/FTC/TAF was interrupted for suspected intolerance in only one case (1.4%). Nucleoside reverse transcriptase inhibitor (NRTI) mutation (T69D/N) emerged in one patient (3.6% of VF) after 47 months of continuous detectable viraemia while on ART. No acquisition of mutations in the integrase gene was observed. Conclusion: Because of its high genetic barrier to resistance, BIC/FTC/TAF could be especially useful in the paediatric population, in which the risk of poor treatment adherence and VF is high. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care.
- Author
-
Nielsen, Ole Haagen and Pardi, Darrell S.
- Subjects
- *
COLITIS diagnosis , *BIOTHERAPY , *IRRITABLE colon diagnosis , *DIARRHEA , *ERYTHEMA , *COLONOSCOPY , *BIOPSY , *HEALTH facilities , *DRUG tolerance , *BISMUTH , *ENDOSCOPIC surgery , *PURINES , *DISEASE relapse , *PIPERIDINE , *MEDICAL protocols , *QUALITY of life , *BILE acids , *COLITIS , *INTESTINAL mucosa , *DIAGNOSTIC errors , *HISTOLOGY , *TERMINATION of treatment , *ELDER care , *ENDOSCOPY , *EDEMA , *BUDESONIDE , *DISEASE risk factors , *SYMPTOMS - Abstract
Microscopic colitis, a diagnosis under the umbrella term of inflammatory bowel disease, is a prevalent cause of watery diarrhea, often with symptoms of urgency and bloating, typically observed in older adults aged ≥ 60 years. Its incidence has been reported to exceed those of ulcerative colitis and Crohn's disease in some geographical areas. Although nonpathognomonic endoscopic abnormalities, including changes of the vascular mucosal pattern; mucosal erythema; edema; nodularity; or mucosal defects, e.g., "cat scratches" have been reported, a colonoscopy is typically macroscopically normal. As reliable biomarkers are unavailable, colonoscopy using random biopsies from various parts of the colon is compulsory. Based on the histological examination under a microscope, the disease is divided into collagenous (with a thickened subepithelial collagenous band) and lymphocytic (with intraepithelial lymphocytosis) colitis, although incomplete forms exist. In routine clinical settings, the disease has a high risk of being misdiagnosed as irritable bowel syndrome or even overlooked. Therefore, healthcare providers should be familiar with clinical features and rational management strategies. A 6–8-week oral budesonide treatment course (9 mg/day) is considered the first-line therapy, but patients often experience relapse when discontinued, or might become intolerant, dependent, or even fail to respond. Consequently, other therapeutic options (e.g., bismuth subsalicylate, biologics, loperamide, bile acid sequestrants, and thiopurines) recommended by available guidelines may be prescribed. Herein, clinically meaningful data is provided based on the latest evidence that may aid in reaching a diagnosis and establishing rational therapy in geriatric care to control symptoms and enhance the quality of life for those affected. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Dihydroazolopyrimidines: Past, Present and Perspectives in Synthesis, Green Chemistry and Drug Discovery.
- Author
-
Desenko, Serhiy M., Gorobets, Mykola Yu., Lipson, Victoria V., Sakhno, Yana I., and Chebanov, Valentyn A.
- Subjects
- *
DRUG discovery , *PHARMACEUTICAL chemistry , *CHEMICAL properties , *DRUG design , *PURINES , *SUSTAINABLE chemistry - Abstract
Dihydroazolopyrimidines are an important class of heterocycles that are isosteric to natural purines and are therefore of great interest primarily as drug‐like molecules. In contrast to the heteroaromatic analogs, synthetic approaches to these compounds were developed much later, and their chemical properties and biological activity have not been studied in detail until recently. In the review, different ways to build dihydroazolopyrimidine systems from different building blocks are described – via the initial formation of a partially hydrogenated pyrimidine ring or an azole ring, as well as a one‐pot assembly of azole and azine fragments. Special attention is given to modern approaches: multicomponent reactions, green chemistry, and the use of non‐classical activation methods. Information on the chemical properties of dihydroazolopyrimidines and the prospects for their use in the design of drugs of various profiles are also summarized in this review. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. P2X4 signalling contributes to hyperactivity but not pain sensitization comorbidity in a mouse model of attention deficit/hyperactivity disorder.
- Author
-
Sader Nehme, Sarah Bou, Sanchez-Sarasua, Sandra, Adel, Ramy, Tuifua, Marie, Ali, Awatef, Essawy, Amina E., Salam, Sherine Abdel, Hleihel, Walid, Boué-Grabot, Eric, and Landry, Marc
- Subjects
LABORATORY mice ,HYPERACTIVITY ,ANIMAL disease models ,CINGULATE cortex ,PAIN threshold ,NEUROANATOMY - Abstract
Introduction: Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by hyperactivity, inattention, and impulsivity that often persist until adulthood. Frequent comorbid disorders accompany ADHD and two thirds of children diagnosed with ADHD also suffer from behavioural disorders and from alteration of sensory processing. We recently characterized the comorbidity between ADHD-like symptoms and pain sensitisation in a pharmacological mouse model of ADHD, and we demonstrated the implication of the anterior cingulate cortex and posterior insula. However, few studies have explored the causal mechanisms underlying the interactions between ADHD and pain. The implication of inflammatory mechanisms has been suggested but the signalling pathways involved have not been explored. Methods: We investigated the roles of purinergic signalling, at the crossroad of pain and neuroinflammatory pathways, by using a transgenic mouse line that carries a total deletion of the P2X4 receptor. Results: We demonstrated that P2X4 deletion prevents hyperactivity in the mouse model of ADHD. In contrast, the absence of P2X4 lowered thermal pain thresholds in sham conditions and did not affect pain sensitization in ADHD-like conditions. We further analysed microglia reactivity and the expression of inflammatory markers in wild type and P2X4KO mice. Our results revealed that P2X4 deletion limits microglia reactivity but at the same time exerts proinflammatory effects in the anterior cingulate cortex and posterior insula. Conclusion: This dual role of P2X4 could be responsible for the differential effects noted on ADHD-like symptoms and pain sensitization and calls for further studies to investigate the therapeutic benefit of targeting the P2X4 receptor in ADHD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Inosine: novel activator of brown adipose tissue and energy homeostasis.
- Author
-
Pfeifer, Alexander, Mikhael, Mickel, and Niemann, Birte
- Subjects
- *
BROWN adipose tissue , *PURINERGIC receptors , *INOSINE , *NUCLEOSIDE transport proteins , *BODY mass index , *FAT cells , *HOMEOSTASIS - Abstract
Inosine is released from brown adipocytes (BAs) upon stress. Inosine activates purinergic P1 receptors, triggering BA activation and white adipocyte browning. Consequently, inosine increases whole-body energy consumption and alleviates diet-induced obesity in mice. The equilibrative nucleoside transporter 1 (ENT1) transports extracellular inosine into cells. By inhibiting ENT1 using dipyridamole, extracellular inosine levels are elevated. A loss-of-function mutation of ENT1 in humans is associated with a reduced body mass index in the carriers. Enhancing inosine concentrations might have therapeutic potential to tackle obesity. Extracellular purinergic molecules act as signaling molecules that bind to cellular receptors and regulate signaling pathways. Growing evidence suggests that purines regulate adipocyte function and whole-body metabolism. Here, we focus on one specific purine: inosine. Brown adipocytes, which are important regulators of whole-body energy expenditure (EE), release inosine when they are stressed or become apoptotic. Unexpectedly, inosine activates EE in neighboring brown adipocytes and enhances differentiation of brown preadipocytes. Increasing extracellular inosine, either directly by increasing inosine intake or indirectly via pharmacological inhibition of cellular inosine transporters, increases whole-body EE and counteracts obesity. Thus, inosine and other closely related purines might be a novel approach to tackle obesity and associated metabolic disorders by enhancing EE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Reconstructive Methodology in the Synthesis of 2-Aminopurine.
- Author
-
Neymash, Artyom O., Ulomsky, Evgeny N., Fedotov, Victor V., Aminov, Semen V., Lyapustin, Daniil N., Gorbunov, Evgeny B., Ishimnikov, Vladislav A., Slepukhin, Pavel A., and Rusinov, Vladimir L.
- Subjects
- *
X-ray diffraction , *GROUP 15 elements , *TRANSFORMATION groups , *RING formation (Chemistry) - Abstract
A fundamentally new synthetic approach to the synthesis of 2-aminopurine has been developed. It consists in the combination of the creation of a condensed polyazotic heterocyclic tetrazolopyrimidine structure, its transformation into triaminopyrimidine, and its subsequent cyclization into 2-aminopurine. The structure of the obtained compounds was established based on spectral characteristics, and the structure of the intermediate compound 5 was established directly by X-ray diffraction analysis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. P2X7 regulates ependymo-radial glial cell proliferation in adult Danio rerio following spinal cord injury
- Author
-
Eva E. Stefanova, Julian Vincent T. Dychiao, Mavis C. Chinn, Matin Borhani, and Angela L. Scott
- Subjects
spinal cord injury ,zebrafish ,neurogenesis ,ependymo-radial glia ,proliferation ,purines ,Science ,Biology (General) ,QH301-705.5 - Published
- 2024
- Full Text
- View/download PDF
38. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
- Author
-
Wolfe, Cameron R, Tomashek, Kay M, Patterson, Thomas F, Gomez, Carlos A, Marconi, Vincent C, Jain, Mamta K, Yang, Otto O, Paules, Catharine I, Palacios, Guillermo M Ruiz, Grossberg, Robert, Harkins, Michelle S, Mularski, Richard A, Erdmann, Nathaniel, Sandkovsky, Uriel, Almasri, Eyad, Pineda, Justino Regalado, Dretler, Alexandra W, de Castilla, Diego Lopez, Branche, Angela R, Park, Pauline K, Mehta, Aneesh K, Short, William R, McLellan, Susan LF, Kline, Susan, Iovine, Nicole M, El Sahly, Hana M, Doernberg, Sarah B, Oh, Myoung-Don, Huprikar, Nikhil, Hohmann, Elizabeth, Kelley, Colleen F, Holodniy, Mark, Kim, Eu Suk, Sweeney, Daniel A, Finberg, Robert W, Grimes, Kevin A, Maves, Ryan C, Ko, Emily R, Engemann, John J, Taylor, Barbara S, Ponce, Philip O, Larson, LuAnn, Melendez, Dante Paolo, Seibert, Allan M, Rouphael, Nadine G, Strebe, Joslyn, Clark, Jesse L, Julian, Kathleen G, de Leon, Alfredo Ponce, Cardoso, Anabela, de Bono, Stephanie, Atmar, Robert L, Ganesan, Anuradha, Ferreira, Jennifer L, Green, Michelle, Makowski, Mat, Bonnett, Tyler, Beresnev, Tatiana, Ghazaryan, Varduhi, Dempsey, Walla, Nayak, Seema U, Dodd, Lori E, Beigel, John H, Kalil, Andre C, and ACTT-4 Study Group
- Subjects
ACTT-4 Study Group ,Humans ,Oxygen ,Sulfonamides ,Azetidines ,Pyrazoles ,Purines ,Dexamethasone ,Treatment Outcome ,Double-Blind Method ,Adolescent ,Adult ,Middle Aged ,Female ,Male ,SARS-CoV-2 ,COVID-19 Drug Treatment ,Clinical Trials and Supportive Activities ,Lung ,Clinical Research ,Prevention ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Good Health and Well Being ,Clinical Sciences ,Public Health and Health Services ,Other Medical and Health Sciences - Abstract
BackgroundBaricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone plus remdesivir in preventing progression to mechanical ventilation or death in hospitalised patients with COVID-19.MethodsIn this randomised, double-blind, double placebo-controlled trial, patients were enrolled at 67 trial sites in the USA (60 sites), South Korea (two sites), Mexico (two sites), Singapore (two sites), and Japan (one site). Hospitalised adults (≥18 years) with COVID-19 who required supplemental oxygen administered by low-flow (≤15 L/min), high-flow (>15 L/min), or non-invasive mechanical ventilation modalities who met the study eligibility criteria (male or non-pregnant female adults ≥18 years old with laboratory-confirmed SARS-CoV-2 infection) were enrolled in the study. Patients were randomly assigned (1:1) to receive either baricitinib, remdesivir, and placebo, or dexamethasone, remdesivir, and placebo using a permuted block design. Randomisation was stratified by study site and baseline ordinal score at enrolment. All patients received remdesivir (≤10 days) and either baricitinib (or matching oral placebo) for a maximum of 14 days or dexamethasone (or matching intravenous placebo) for a maximum of 10 days. The primary outcome was the difference in mechanical ventilation-free survival by day 29 between the two treatment groups in the modified intention-to-treat population. Safety analyses were done in the as-treated population, comprising all participants who received one dose of the study drug. The trial is registered with ClinicalTrials.gov, NCT04640168.FindingsBetween Dec 1, 2020, and April 13, 2021, 1047 patients were assessed for eligibility. 1010 patients were enrolled and randomly assigned, 516 (51%) to baricitinib plus remdesivir plus placebo and 494 (49%) to dexamethasone plus remdesivir plus placebo. The mean age of the patients was 58·3 years (SD 14·0) and 590 (58%) of 1010 patients were male. 588 (58%) of 1010 patients were White, 188 (19%) were Black, 70 (7%) were Asian, and 18 (2%) were American Indian or Alaska Native. 347 (34%) of 1010 patients were Hispanic or Latino. Mechanical ventilation-free survival by day 29 was similar between the study groups (Kaplan-Meier estimates of 87·0% [95% CI 83·7 to 89·6] in the baricitinib plus remdesivir plus placebo group and 87·6% [84·2 to 90·3] in the dexamethasone plus remdesivir plus placebo group; risk difference 0·6 [95% CI -3·6 to 4·8]; p=0·91). The odds ratio for improved status in the dexamethasone plus remdesivir plus placebo group compared with the baricitinib plus remdesivir plus placebo group was 1·01 (95% CI 0·80 to 1·27). At least one adverse event occurred in 149 (30%) of 503 patients in the baricitinib plus remdesivir plus placebo group and 179 (37%) of 482 patients in the dexamethasone plus remdesivir plus placebo group (risk difference 7·5% [1·6 to 13·3]; p=0·014). 21 (4%) of 503 patients in the baricitinib plus remdesivir plus placebo group had at least one treatment-related adverse event versus 49 (10%) of 482 patients in the dexamethasone plus remdesivir plus placebo group (risk difference 6·0% [2·8 to 9·3]; p=0·00041). Severe or life-threatening grade 3 or 4 adverse events occurred in 143 (28%) of 503 patients in the baricitinib plus remdesivir plus placebo group and 174 (36%) of 482 patients in the dexamethasone plus remdesivir plus placebo group (risk difference 7·7% [1·8 to 13·4]; p=0·012).InterpretationIn hospitalised patients with COVID-19 requiring supplemental oxygen by low-flow, high-flow, or non-invasive ventilation, baricitinib plus remdesivir and dexamethasone plus remdesivir resulted in similar mechanical ventilation-free survival by day 29, but dexamethasone was associated with significantly more adverse events, treatment-related adverse events, and severe or life-threatening adverse events. A more individually tailored choice of immunomodulation now appears possible, where side-effect profile, ease of administration, cost, and patient comorbidities can all be considered.FundingNational Institute of Allergy and Infectious Diseases.
- Published
- 2022
39. A fly GWAS for purine metabolites identifies human FAM214 homolog medusa, which acts in a conserved manner to enhance hyperuricemia-driven pathologies by modulating purine metabolism and the inflammatory response
- Author
-
Hilsabeck, Tyler AU, Liu-Bryan, Ru, Guo, Tracy, Wilson, Kenneth A, Bose, Neelanjan, Raftery, Daniel, Beck, Jennifer N, Lang, Sven, Jin, Kelly, Nelson, Christopher S, Oron, Tal, Stoller, Marshall, Promislow, Daniel, Brem, Rachel B, Terkeltaub, Robert, and Kapahi, Pankaj
- Subjects
Genetics ,Biotechnology ,Aetiology ,2.1 Biological and endogenous factors ,Inflammatory and immune system ,Animals ,Humans ,Mice ,Drosophila melanogaster ,Genome-Wide Association Study ,Gout ,Hyperuricemia ,Inflammation ,Purines ,Uric Acid ,Drosophila Proteins ,GWAS ,Drosophila ,Lifespan - Abstract
Elevated serum urate (hyperuricemia) promotes crystalline monosodium urate tissue deposits and gout, with associated inflammation and increased mortality. To identify modifiers of uric acid pathologies, we performed a fly Genome-Wide Association Study (GWAS) on purine metabolites using the Drosophila Genetic Reference Panel strains. We tested the candidate genes using the Drosophila melanogaster model of hyperuricemia and uric acid crystallization ("concretion formation") in the kidney-like Malpighian tubule. Medusa (mda) activity increased urate levels and inflammatory response programming. Conversely, whole-body mda knockdown decreased purine synthesis precursor phosphoribosyl pyrophosphate, uric acid, and guanosine levels; limited formation of aggregated uric acid concretions; and was sufficient to rescue lifespan reduction in the fly hyperuricemia and gout model. Levels of mda homolog FAM214A were elevated in inflammatory M1- and reduced in anti-inflammatory M2-differentiated mouse bone marrow macrophages, and influenced intracellular uric acid levels in human HepG2 transformed hepatocytes. In conclusion, mda/FAM214A acts in a conserved manner to regulate purine metabolism, promotes disease driven by hyperuricemia and associated tissue inflammation, and provides a potential novel target for uric acid-driven pathologies.
- Published
- 2022
40. Azetidines‐Containing Fluorescent Purine Analogs: Synthesis and Photophysical Properties
- Author
-
Hadidi, Kaivin and Tor, Yitzhak
- Subjects
Antimetabolites ,Azetidines ,Fluorescent Dyes ,Nucleosides ,Purines ,Water ,fluorescence ,heterocycles ,modified nucleosides ,nucleosides ,RNA ,Chemical Sciences ,General Chemistry - Abstract
Analogues of N,N-dimethyladenine exploiting both thieno-and isothiazolo-pyrimidine cores were modified with 3-subsituted azetidines to yield visibly emissive and responsive fluorophores. The emission quantum yields, among the highest seen for purine analogues (0.64 and 0.77 in water and dioxane respectively), correlated with the Hammett inductive constants of the substituents on the azetidine ring. Ribosylation of the difluoroazetidino-modified nucleobase yielded an emissive nucleoside that displayed a substantially lower emission quantum yield in water, compared to the precursor nucleobase. Importantly, high emission quantum yield was restored in deuterium oxide, which highlights the potential impact of the sugar moiety on the photophysical features of fluorescent nucleosides, a functionality usually considered non-chromophoric and photophysically benign.
- Published
- 2022
41. Adenine nucleotide translocase 2 silencing promotes metabolic adaptations and anoikis in P19 embryonal carcinoma stem cells
- Subjects
Adenylic acid ,Stem cells ,Cancer ,Purines ,Stem cell research ,Health - Abstract
2024 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]
- Published
- 2024
42. Comprehensive evaluation and prediction of editing outcomes for near-PAMless adenine and cytosine base editors
- Subjects
Editors ,Physical fitness ,Purines ,Health - Abstract
2024 MAY 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]
- Published
- 2024
43. SERS analysis of cancer cell-secreted purines reveals a unique paracrine crosstalk in MTAP-deficient tumors.
- Author
-
Valera, Pablo S., Plou, Javier, García, Isabel, Astobiza, Ianire, Viera, Cristina, Aransay, Ana M., Martin, José E., Sasselli, Ivan R., Carracedo, Arkaitz, and Liz-Marzán, Luis M.
- Subjects
- *
SERS spectroscopy , *PURINES , *STROMAL cells , *CANCER cells , *TUMOR microenvironment , *REMANUFACTURING - Abstract
The tumor microenvironment (TME) is a dynamic pseudoorgan that shapes the development and progression of cancers. It is a complex ecosystem shaped by interactions between tumor and stromal cells. Although the traditional focus has been on the paracrine communication mediated by protein messengers, recent attention has turned to the metabolic secretome in tumors. Metabolic enzymes, together with exchanged substrates and products, have emerged as potential biomarkers and therapeutic targets. However, traditional techniques for profiling secreted metabolites in complex cellular contexts are limited. Surface-enhanced Raman scattering (SERS) has emerged as a promising alternative due to its nontargeted nature and simplicity of operation. Although SERS has demonstrated its potential for detecting metabolites in biological settings, its application in deciphering metabolic interactions within multicellular systems like the TME remains underexplored. In this study, we introduce a SERS-based strategy to investigate the secreted purine metabolites of tumor cells lacking methylthioadenosine phosphorylase (MTAP), a common genetic event associated with poor prognosis in various cancers. Our SERS analysis reveals that MTAP-deficient cancer cells selectively produce methylthioadenosine (MTA), which is taken up and metabolized by fibroblasts. Fibroblasts exposed to MTA exhibit: i) molecular reprogramming compatible with cancer aggressiveness, ii) a significant production of purine derivatives that could be readily recycled by cancer cells, and iii) the capacity to secrete purine derivatives that induce macrophage polarization. Our study supports the potential of SERS for cancer metabolism research and reveals an unprecedented paracrine crosstalk that explains TME reprogramming in MTAP-deleted cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
44. Purines and Adenosine Receptors in Osteoarthritis.
- Author
-
Cronstein, Bruce N. and Angle, Siddhesh R.
- Subjects
- *
LIPOSOMES , *ADENOSINES , *PURINES , *TOPICAL drug administration , *OSTEOARTHRITIS - Abstract
OA is a common and debilitating condition that restricts mobility and diminishes the quality of life. Recent work indicates that the generation of adenosine at the cell surface is an important mediator of chondrocyte homeostasis, and topical application of adenosine in a slow-release form (liposomes) can halt the progression of OA and diminish the pain associated with OA. Here, we review the evidence indicating that adenosine, acting at A2A receptors, plays a critical role in endogenous and exogenous treatment and reversal of OA. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Effectiveness and Safety of Tenofovir Alafenamide in Treatment-Naive and Treatment-Experienced Patients with Chronic Hepatitis B: Results of a Real-World Study from China.
- Author
-
Lan-Qing Li, Fa-Da Wang, Jing Zhou, Meng-Lan Wang, Yachao Tao, and En-Qiang Chen
- Subjects
- *
DRUG efficacy , *HOSPITALS , *GLOMERULAR filtration rate , *TRIGLYCERIDES , *TENOFOVIR , *PURINES , *VIRAL load , *RETROSPECTIVE studies , *ACQUISITION of data , *MEDICAL records , *DESCRIPTIVE statistics , *CHRONIC hepatitis B , *PATIENT safety , *AMIDES , *OUTPATIENT services in hospitals , *ALANINE aminotransferase , *CREATININE , *CHOLESTEROL , *EVALUATION - Abstract
Background: Tenofovir alafenamide (TAF) has been effective against naive patients with chronic hepatitis B (CHB) in phase 3 clinical trials. However, its real-world data are still limited. Objectives: This study aimed to investigate the effectiveness and safety of TAF in real-life situations in treatment-naive (TN) and treatment-experienced (TE) CHB patients in China. Methods: This retrospective study enrolled TAF-treated patients between January 2019 and October 2020 at the outpatient clinic of West China Hospital. The primary endpoint was the rates of virologic response (VR), and the secondary endpoints were the proportion of normal alanine aminotransferase (ALT) and quantitative hepatitis B surface antigen (qHBsAg) levels. Safety endpoints comprised serum lipid profiles, changes in estimated glomerular filtration rate (eGFR), and serum creatinine (Scr). Results: A total of 161 TAF-treated patients were enrolled, including 49 TN patients and 112 TE patients. In the TN group, the VRrate at week 96 was 91.7% (22/24), and the proportion of normal ALT at week 96 was 95.8% (23/24). In the TE group, the VRrate at week 96 was 97.2% (69/71), and the proportion of normal ALT at week 96 was 90.1% (64/71). Serum qHBsAg levels decreased from 2930 to 1292 IU/mL in the TN group and 1158 to 533 IU/mL in the TE group during 96 weeks of treatment (P = 0.05). For patients in the TN and TE groups, when compared to baseline measurements, serum creatinine increased (+7.91 vs. +6.62 mL/min/1.73 m², P = 0.52) while eGFR decreased (-11.46 vs. -10.90 µmol/L, P = 0.82) at week 96. Simultaneously, triglycerides (TG) (+ 0.39 vs. + 0.31 mmol/L, P = 0.32), total cholesterol (TC) (+0.65 vs. +0.52 mmol/L, P = 0.02), and low-density lipoprotein cholesterol (LDL-C) (+0.25 vs. +0.25 mmol/L, P = 0.60) increased over time. Conclusions: TAF was highly effective in TN and TE CHB patients. However, there are potential risks in eGFR decrease and a continuous increase in lipidemia with the prolongation of medication time. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Migraine signaling pathways: purine metabolites that regulate migraine and predispose migraineurs to headache.
- Author
-
Biringer, Roger Gregory
- Abstract
Migraine is a debilitating disorder that afflicts over 1 billion people worldwide, involving attacks that result in a throbbing and pulsating headache. Migraine is thought to be a neurovascular event associated with vasoconstriction, vasodilation, and neuronal activation. Understanding signaling in migraine pathology is central to the development of therapeutics for migraine prophylaxis and for mitigation of migraine in the prodrome phase before pain sets in. The fact that both vasoactivity and neural sensitization are involved in migraine indicates that agonists which promote these phenomena may very well be involved in migraine pathology. One such group of agonists is the purines, in particular, adenosine phosphates and their metabolites. This manuscript explores what is known about the relationship between these metabolites and migraine pathology and explores the potential for such relationships through their known signaling pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Infrared Spectral Signatures of Nucleobases in Interstellar Ices I: Purines.
- Author
-
Rosa, Caroline Antunes, Bergantini, Alexandre, Herczku, Péter, Mifsud, Duncan V., Lakatos, Gergő, Kovács, Sándor T. S., Sulik, Béla, Juhász, Zoltán, Ioppolo, Sergio, Quitián-Lara, Heidy M., Mason, Nigel J., and Lage, Claudia
- Subjects
- *
BASE pairs , *PURINES , *ASTRONOMICAL observations , *GUANINE , *INFRARED absorption , *ADENINE - Abstract
The purine nucleobases adenine and guanine are complex organic molecules that are essential for life. Despite their ubiquitous presence on Earth, purines have yet to be detected in observations of astronomical environments. This work therefore proposes to study the infrared spectra of purines linked to terrestrial biochemical processes under conditions analogous to those found in the interstellar medium. The infrared spectra of adenine and guanine, both in neat form and embedded within an ice made of H2O:NH3:CH4:CO:CH3OH (10:1:1:1:1), were analysed with the aim of determining which bands attributable to adenine and/or guanine can be observed in the infrared spectrum of an astrophysical ice analogue rich in other volatile species known to be abundant in dense molecular clouds. The spectrum of adenine and guanine mixed together was also analysed. This study has identified three purine nucleobase infrared absorption bands that do not overlap with bands attributable to the volatiles that are ubiquitous in the dense interstellar medium. Therefore, these three bands, which are located at 1255, 940, and 878 cm−1, are proposed as an infrared spectral signature for adenine, guanine, or a mixture of these molecules in astrophysical ices. All three bands have integrated molar absorptivity values (ψ) greater than 4 km mol−1, meaning that they should be readily observable in astronomical targets. Therefore, if these three bands were to be observed together in the same target, then it is possible to propose the presence of a purine molecule (i.e., adenine or guanine) there. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. Efficient removal of purine compounds from solutions via biomass carbons derived from pomelo peel.
- Author
-
Chen, Dai Di, Li, Qingxin, and Wu, Jin Chuan
- Subjects
- *
SOYMILK , *GRAPEFRUIT , *URIC acid , *BIOMASS , *FOOD additives , *ADSORPTION capacity , *CARBON analysis , *PURINES - Abstract
The high purine diet could result in the increase of the level of blood uric acid, causing serious health problems such as hyperuricemia, gout, nephropathy and cardiovascular diseases. To find out a safe, cheap and super adsorption material for removing purines in stomach or pretreating high-purine beverages, we used different tissues of pomelo peel to prepare biomass carbon by drying, chemical modification and carbonization and then applied it to remove purine compounds in strong acidic solution, beer and soybean milk. The characteristic analysis of pomelo-peel-derived carbons (PPCs) indicated that the preparation methods significantly affected the structures and adsorption capacities of PPCs. Compared with the biomass carbon derived from bamboo, PPCs exhibited higher adsorption capabilities for purine compounds in strong acidic solution (adsorption rates > 99% in 15 min) and soybean milk (adsorption rates > 56% in 30 min) but slightly lower adsorption capabilities in beer (adsorption rates > 52% in 30 min). In addition, the adsorption capabilities of PPCs for purine compounds in beer and soybean milk were not obviously affected by temperatures. Therefore, PPCs are promising absorbents for applications in removing purine compounds from beverages to produce low-purine, healthier products for treating hyperuricemia. The strong adsorption capabilities of PPCs on purine compounds in strong acidic environment also provides a possibility of using the PPCs as food additives for removing purines in stomach for healthcare applications such as gout prevention after confirming their biosafety. [Display omitted] • The structures of PPCs were significantly affected by the preparation methods. • PPCs showed superior ability for removing purines in strong acidic solution than EBBC. • PPCs showed higher adsorption ability for purines in high-purine beverages than EBBC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
49. Looking for the unexpected in purine and pyrimidine metabolism.
- Author
-
Jordheim, Lars Petter, Radu, Caius G., and Peters, Godefridus J.
- Abstract
Abstract In June 2023, the Purine and Pyrimidine Society (PPS) organized the 20th biennial symposium on Purine and Pyrimidine metabolism (PP23). The symposium was organized in Los Angeles, California, USA, by Pr Caius Radu affiliated to UCLA. The scientific program covered various topics such as inborn errors, cancer, immunity, enzymatic reactions, drug development etc and was presented at 9 sessions over three days. The current issue of
Nucleosides, Nucleotides & Nucleic Acids is a special issue covering proceedings from PP23-presentations and other PPS-related manuscripts, and in this editorial, we will give an overview of the scientific program of the meeting. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
50. Sentencia del Tribunal Superior de Justicia de Castilla y León (Valladolid), de 22 de junio de 2023 (Sala de lo Contencioso-Administrativo, Sección 1, Ponente: Francisco Javier Zataraín Valdemoro).
- Author
-
Blasco Hedo, Eva
- Subjects
- *
PURINES , *TRANSCRIPTION (Linguistics) , *TRANSGENIC organisms - Abstract
La Junta de Castilla y León plantea en este caso concreto un recurso contenciosoadministrativo contra el Acuerdo del Ayuntamiento de Payo de Ojeda de 14 de julio de 2020, por el que se aprueba la Ordenanza Municipal reguladora de vertidos de origen industrial, agrícola y ganadero del Municipio de Payo de Ojeda (Palencia), habiendo comparecido como parte demandada el ayuntamiento de dicha localidad. Con carácter previo, se transcribe el contenido íntegro de la Ordenanza, cuyo objeto es “la regulación del almacenamiento, transporte y distribución en las fincas rústicas de labor del municipio de Payo de Ojeda de los estiércoles, purines y otros residuos procedentes de fuentes de origen industrial, agrícola y ganadero con el fin de reducir al máximo las molestias y contaminación que dichas fuentes pueden ocasionar”. La Administración autonómica basa su recurso en los siguientes motivos: 1.- Existencia de imprecisiones terminológicas en la Ordenanza impugnada en cuanto al uso del término "residuos" y de la expresión "vertido de residuos". 2.- Nulidad de pleno derecho de la ordenanza por falta de estudio científico o documento técnico que acredite que en ese municipio existe un riesgo para la salud o para el medio ambiente derivado de estiércoles, purines y lodos de depuración, única circunstancia que podría justificar la elaboración de tal Norma. Tampoco se aporta en el expediente el resultado de las analíticas de agua potable que se aluden en el Preámbulo. 3.- Nulidad de pleno derecho de la ordenanza por vulneración de la Directiva 2006/123/CE, del Parlamento Europeo y del Consejo, de 12 de diciembre de 2006, relativa a los servicios en el mercado interior como en la Ley 20/2013, de 9 de diciembre, de Garantía de la Unidad de Mercado. 4.- Extralimitación competencial de la administración demandada porque el establecimiento de las condiciones ambientales mínimas y de ubicación para las actividades o instalaciones ganaderas de Castilla y León, entre las que se encuentran el almacenamiento y aplicación de estiércoles y purines, están regulados en el Decreto 4/2018, 22 de febrero (concretamente en [ABSTRACT FROM AUTHOR]
- Published
- 2023
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.